Covid Delta Endoscopy Priority Tool

Posted Sunday August 22, 2021
  • This advice will be reviewed regularly with key stakeholders, particularly when the Alert is nuanced from National to Regional
  • GI Endoscopy is a key diagnostic and therapeutic investigation
  • It is still unclear in terms of understanding how this outbreak will affect emergency and elective work. The situation is rapidly evolving.
  • The following Position Statement will require a full review in light of the Delta Outbreak. NZSG will work on this in the next 7 – 14 days with Key Stakeholders.
  • NZSG fully support all Public Health measures including the Elimination strategy and Vaccination programme, and Ministry of Health Guidelines that advise people to not delay seeking help for any health needs at any Alert Level.
  • NZSG is in regular contact with many GI Endoscopists, and will do everything possible to communicate to enable cooperation between departments and DHBs to support provision of specialist GI Endoscopy and Gastroenterology Care, as well as the recommencement of Bowel Screening as soon as possible

This is based on the 2020 guideline, which will be reviewed in coming weeks and is available on the NZSG website.

Keep safe and be kind. Any korero / feedback is welcomed, please email Anna or contact the President / an Exec member directly. You can also find this table on our website under Covid 19 section here

Nga mihi nui,

Zoe Raos

NZSG President

Gallery

Attachments

Related Articles

2025 Advanced Gastroenterology Training Opportunities (Match 2024) Information

Tuesday April 2, 2024

NZSG will be accepting applications for placements from the 8th of April 2024. The final date for applying is Friday the...

Vacancies Events + 2 More

Read more »

NZCCRTGE - Conjoint Committee News

Friday March 15, 2024

The NZCCRTGE has made a few changes we'd like to let you know about

News

Read more »

Supply Issue Notice from Pharmac

Thursday February 15, 2024

We've received news about long-term supply issue affecting the Dipentum brand of olsalazine (250 mg capsules and 500 mg ...

News Pharma News

Read more »